These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30446337)

  • 1. PHA eludes macrophage suppression to activate CD8
    Lomakova YD; Londregan J; Maslanka J; Goldman N; Somerville J; Riggs JE
    Immunobiology; 2019 Jan; 224(1):94-101. PubMed ID: 30446337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High macrophage PD-L1 expression not responsible for T cell suppression.
    Goldman N; Lomakova YD; Londregan J; Bucknum A; DePierri K; Somerville J; Riggs JE
    Cell Immunol; 2018 Feb; 324():50-58. PubMed ID: 29305065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment.
    Xiong H; Mittman S; Rodriguez R; Moskalenko M; Pacheco-Sanchez P; Yang Y; Nickles D; Cubas R
    Cancer Res; 2019 Apr; 79(7):1493-1506. PubMed ID: 30679180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Sunitinib and PD-L1 Blockade Enhances Anticancer Efficacy of TLR7/8 Agonist-Based Nanovaccine.
    Kim H; Khanna V; Kucaba TA; Zhang W; Ferguson DM; Griffith TS; Panyam J
    Mol Pharm; 2019 Mar; 16(3):1200-1210. PubMed ID: 30620878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production.
    Yamazaki T; Akiba H; Koyanagi A; Azuma M; Yagita H; Okumura K
    J Immunol; 2005 Aug; 175(3):1586-92. PubMed ID: 16034097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
    Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
    J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage regulation of B cell proliferation.
    Goldman N; Valiuskyte K; Londregan J; Swider A; Somerville J; Riggs JE
    Cell Immunol; 2017 Apr; 314():54-62. PubMed ID: 28238361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of migration inhibitory and migration stimulatory factors in two lines of mice genetically selected for high or low responsiveness to phytohemagglutinin. 1. Migration stimulatory factor(s) from T and B cells of immune spleen.
    Gauthier-Rahman S; el-Gharbi N; Siddiqui MU; Couderc J; Decreusefond C; Stiffel C
    Exp Clin Immunogenet; 1991; 8(3):140-58. PubMed ID: 1799458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spleen-derived IFN-γ induces generation of PD-L1
    Langereis JD; Pickkers P; de Kleijn S; Gerretsen J; de Jonge MI; Kox M
    J Leukoc Biol; 2017 Dec; 102(6):1401-1409. PubMed ID: 28974543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8
    Li J; Lee Y; Li Y; Jiang Y; Lu H; Zang W; Zhao X; Liu L; Chen Y; Tan H; Yang Z; Zhang MQ; Mak TW; Ni L; Dong C
    Immunity; 2018 Apr; 48(4):773-786.e5. PubMed ID: 29625896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin Augments Antitumor T-Cell Responses Leading to a Potent Therapeutic Effect in Combination With PD-L1 Blockade.
    Wakita D; Iwai T; Harada S; Suzuki M; Yamamoto K; Sugimoto M
    Anticancer Res; 2019 Apr; 39(4):1749-1760. PubMed ID: 30952714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of macaque testicular leucocyte populations and T-lymphocyte immunity.
    De Rose R; Fernandez CS; Hedger MP; Kent SJ; Winnall WR
    J Reprod Immunol; 2013 Dec; 100(2):146-56. PubMed ID: 24139314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses.
    Wahl C; Bochtler P; Chen L; Schirmbeck R; Reimann J
    Gastroenterology; 2008 Sep; 135(3):980-8. PubMed ID: 18621049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of macrophage-derived nitric oxide in suppression of lymphocyte proliferation during blood-stage malaria.
    Ahvazi BC; Jacobs P; Stevenson MM
    J Leukoc Biol; 1995 Jul; 58(1):23-31. PubMed ID: 7542305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
    Yin W; Song Y; Liu Q; Wu Y; He R
    Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of migration inhibitory and migration stimulatory factors in two lines of mice genetically selected for high or low responsiveness to phytohemagglutinin. 2. Effects of mitogenic or allogeneic stimulation.
    Gauthier-Rahman S; Suzuki K; Couderc J; el-Gharbi N; Decreusefond C; Stiffel C
    Exp Clin Immunogenet; 1991; 8(3):159-76. PubMed ID: 1839210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity.
    Juneja VR; McGuire KA; Manguso RT; LaFleur MW; Collins N; Haining WN; Freeman GJ; Sharpe AH
    J Exp Med; 2017 Apr; 214(4):895-904. PubMed ID: 28302645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary suppression of T cell activation by peritoneal macrophages and CTLA-4-Ig.
    Yeh K; Silberman D; Gonzalez D; Riggs J
    Immunobiology; 2007; 212(1):1-10. PubMed ID: 17270704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells.
    Zheng Z; Sun R; Zhao HJ; Fu D; Zhong HJ; Weng XQ; Qu B; Zhao Y; Wang L; Zhao WL
    Mol Cancer; 2019 Mar; 18(1):54. PubMed ID: 30925928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.